Metagenomi, Inc. Common Stock
MGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9 | $9 | $4 | $10 |
| % Growth | 1.7% | 106.3% | -57.1% | – |
| Cost of Goods Sold | $1 | $23 | $0 | $0 |
| Gross Profit | $7 | -$14 | $4 | $10 |
| % Margin | 84.7% | -164.4% | 100% | 100% |
| R&D Expenses | $24 | $23 | $25 | $23 |
| G&A Expenses | $0 | $7 | $7 | $7 |
| SG&A Expenses | $6 | $7 | $7 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$23 | $0 | $0 |
| Operating Expenses | $30 | $7 | $32 | $30 |
| Operating Income | -$23 | -$21 | -$28 | -$21 |
| % Margin | -263.8% | -246.5% | -674.1% | -214.5% |
| Other Income/Exp. Net | $2 | $1 | $3 | -$4 |
| Pre-Tax Income | -$21 | -$20 | -$25 | -$25 |
| Tax Expense | -$0 | $0 | $0 | -$1 |
| Net Income | -$20 | -$20 | -$25 | -$23 |
| % Margin | -235.5% | -233.9% | -606.7% | -243.4% |
| EPS | -0.55 | -0.54 | -0.68 | -0.63 |
| % Growth | -1.9% | 20.6% | -7.9% | – |
| EPS Diluted | -0.55 | -0.54 | -0.68 | -0.63 |
| Weighted Avg Shares Out | 37 | 37 | 37 | 37 |
| Weighted Avg Shares Out Dil | 37 | 37 | 37 | 37 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$19 | -$20 | -$26 | -$19 |
| % Margin | -222.9% | -230.8% | -641.2% | -199.3% |